Advisory Board December 19, 2024
Science last week named the HIV prevention drug lenacapavir as its 2024 Breakthrough of the Year, saying it represented “a pivotal step toward diminishing HIV/AIDS as a global health crisis.”
A breakthrough drug in HIV prevention
Although there have been significant advances in HIV treatments and prevention methods over the last few decades, more than 1 million people are still infected by the virus every year, and reducing the number of new infections has largely stalled.
However, a new drug called lenacapavir “might break the impasse,” Science writes. Lenacapavir, which is manufactured by Gilead Sciences, was first approved by FDA as a treatment for multi-drug-resistant HIV in 2022. Now, new research suggests that it may be effective in preventing...
Today's Sponsors
Today's Sponsor